`
`CENTER FOR DRUG EVALUATION AND
`
`
`
`
`
`RESEARCH
`
`
`
`
`
`APPLICATION NUMBER:
`
`
`
`210875Orig1s000
`
`
`
`
`
`
`
`OFFICER/EMPLOYEE LIST
`
`
`
`MEMORANDUM
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`
` PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`DATE:
`
`TO:
`
`05/12/2020
`
`Administrative file for NDA 210875
`
`FROM:
`
`
`Jack Dan, RPh, Regulatory Health Project Manager
`Division of Neurology 1, Office of Neuroscience
`SUBJECT: Officer/Employee List for NDA 210875
`APPLICATION/DRUG:
`
`NDA 210875, Kynmobi, (apomorphine) sublingual film
`
`
`The following officers or employees of FDA participated in the decision to approve this
`
`application and consented to be identified on this list:
`
`Ahmed, Mariam
`Alfaro, Cara
`Bastings, Eric
`Bergmann, Kenneth
`Callahan, Catherine
`Dan, Jack
`Falade, Leah
`Flowers, Charlene
`Kambhampati, Rao V
`Mckinney, LuAnn
`Nguyen, Maria
`Ogbonna, Casmir
`PerezVilar, Silvia
`Peters, Tracy
`Podskalny, Gerald
`Sabarinath, Sreedharan
`Shah, Dhara
`White, Lolita
`Williams, Marcia Britt
`Wilson, Wendy
`Wu, Ta-Chen
`Zhang, Ben
`Zhang, Xiangmin
`
`
`
`Reference ID: 4607085Reference ID: 4613103
`
`
`
`Signature Page 1 of 1
`--------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed
`electronically. Following this are manifestations of any and all
`electronic signatures for this electronic record.
`--------------------------------------------------------------------------------------------
`/s/
`------------------------------------------------------------
`
`JACK DAN
`05/12/2020 10:26:08 AM
`
`
`
`Reference ID: 4607085Reference ID: 4613103
`
`